Exitile`s Access to Hygienic Solutions

Laboratory products

Exitile`s Access to Hygienic Solutions

20 Dec, 2005

Published over 20 years ago. See the latest and most current information on Laboratory products.

Exitile have long been recognised at the UK’s leading manufacturer of metal access panels and inline with their continued product development can now offer silver antimicrobial protection, considered unique in this type of product which makes them an obvious choice in areas of possible risk. The protection is provided through a partnership with BioCote Ltd, an advanced antimicrobial technology based on Silver.

The BioCote treatment is incorporated into the moulding process when producing the major constituents of the Exitile access panels, including the visible areas of frames and doors. The protection provided is long-term and deals with the problem of health threatening micro-organisms that can be encountered within medical and clinical environments.

Exitile understand the importance of cleaning as an immediate action to eliminate bacteria, however if cleaning programmes fail or areas are neglected then surfaces can become susceptible to bacteria build up. Outlined in the NHS Estates Cleaning Manual are cleaning methods, access panels are not specified for a cleaning programme, so when are they cleaned? This is when there is a need for a second line of defence to inhibit bacterial growth and why Exitile have partnered with BioCote to offer a hygienic solution.

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
World Bank commits USD600m to clean air programmes in Uttar Pradesh and Haryana
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Fifty years on, the EU reaffirms its commitment to Seveso-level industrial safety oversight
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow